期刊文献+

WAVE1基因在K562/A02白血病细胞多药耐药中的作用 被引量:7

Role of WAVE1 in drug resistance of K562/A02 leukemia cells
原文传递
导出
摘要 目的探讨 WASP 家族 Verprolin 同源蛋白1(WAVE1)基因在 K562/A02白血病细胞多药耐药机制中的作用。方法将 pEFBOS-WAVE1真核表达质粒转染 K562细胞构建 WAVE1高表达的 K562细胞,将 WAVE1基因的特异性小片段干扰 RNA(WAVE1 siRNA)转染 K562/A02细胞构建WAVE1低表达的 K562/A02细胞。Western blot 和 RT-PCR 法检测基因转染前后 K562/A02细胞及K562细胞 WAVE1基因及蛋白的表达;可溶性噻唑盐 WST-8染色法检测阿霉素对转染前后细胞的半数抑制浓度(IC_(50));Hoechest33258染色法检测细胞形态学改变并计算凋亡细胞百分率;RT-PCR 检测多药耐药基因 mdrl mRNA 表达;Western blot 检测 Bcl-2表达。结果①与 K562细胞相比,K562/A02细胞 WAVE1 mRNA 表达水平增加70%,蛋白表达水平增加63%。②转染 WAVE1基因的 K562细胞WAVE1过表达,并降低了对阿霉素的药物敏感性,使 IC_(50)从转染前的(0.35±0.00)μg/ml,增加到(2.99±0.12)μg/ml,在阿霉素浓度为1、5μg/ml时,凋亡细胞分别下降30%、35%。③转染 WAVE1siRNA 的 K562/A02细胞 WAVE1蛋白表达水平与未转染组相比明显降低,并可增强对阿霉素的药物敏感性,使 IC_(50)从转染前的(4.29±0.15)μg/ml下降到(1.85±0.07)μg/ml,阿霉素浓度为1、5μg/ml时,凋亡细胞分别增加24%、21%。④转染 WAVE1的 K562细胞 mdr1基因和 Bcl-2蛋白表达水平均增高,而转染 WAVE1 siRNA 的 K562/A02细胞 mdr1基因和 Bcl-2蛋白表达水平比转染前明显降低。结论 WAVE1参与了 K562/A02细胞多药耐药的形成,其机制可能与调控 mdr1和 Bcl-2水平有关。 Objective To investigate if WAVE1 is involved in muh drug-resistance (MDR) of human leukemia cell line K562/A02. Methods The level of WAVE1 in K562 and K562/A02 cells was assayed by Western blot and RT-PCR; K562 cells and K562/A02 cells were transient transfected with pEFBOSWAVE1 reconstructed plasmid or specifically siRNA to WAVE1. 50 % inhibition concentration (IC50) of doxorubicin on K562/A02 was determined by WST-8 assay. Hoechst33258 staining was used to examine cell morphological changes and to calculate percentage of apoptotic nuclei. The mRNA level of mdr1 was assayed by RT-PCR. The Bcl-2 protein was assayed by Western blot. Results (1) The WAVE1 expression at mRNA and protein level in K562/A02 cells was increased by about 70% and 63% respectively as compared with that in K562 cells. (2)Overexpression of WAVE1 in K562 cells by transient transfection significantly increased the resistance to doxorubicin, and increased IC50 from (0.05 ±0.00) μg/ml to (2.99 ±0.12) μg/ml, and at 1 μg/ml or 5 μg/ml of doxorubicin treatment, cell apoptotic nuclei rate was decreased by 30% or 35% respectively. (3)Suppression of WAVE1 in K562/A02 cells by siRNA resulted in a reversal of MDR to doxorubicin, and decreased IC50 from (4.29 ± 0.15 ) μg/ml to ( 1.85 ± 0.07 ) μg/ml, and at 1 μg/ml or 5 μg/ml of doxorubicin treatment, cell apoptotic nuclei rate was increased by 24% or 21% respectively. (4)Overexpression of WAVE1 in K562 cells significantly increased the mdr1 mRNA and the Bcl-2 protein, and suppression of WAVE1 in K562/A02 cells by siRNA decreased the mRNA and the protein. Conclusion WAVE1 involves in the MDR mechanisms in K562/A02 leukemia cells through regulation the level of mdr1 and Bcl-2.
出处 《中华血液学杂志》 CAS CSCD 北大核心 2007年第6期379-382,共4页 Chinese Journal of Hematology
关键词 基因 WAVE1 抗药性 多药 细胞系 K562/A02 RNA干扰 Gene, WAVE1 Resistance, multidrug Cell line, K562/A02 Small interference RNA Gene recombination
  • 相关文献

参考文献5

二级参考文献17

  • 1谢兆霞,谭达人,谢俊明,秦群,谭桂山,徐平声.“拮新康”的逆转耐药与抗肿瘤作用的研究[J].中国现代医学杂志,1996,6(4):18-19. 被引量:11
  • 2Sinclair P B, Sorour A, Martineau M, et d. A fluorescence in situ hybridization map of 6q deletions in acute lymphocytic leukemia:identification and analysis of a candidate tumor suppressor gene.Cancer Res, 2004, 64 (12): 4089-4098.
  • 3Takeuchi S, Seriu T, van Dongen J J, et al. Allelotype analysis in relapsed childhood acute lymphoblastic leukemia. Oncogene, 2003,22 (44): 6970-6976.
  • 4Takeuchi S, Koike M, Seriu T, et al. Frequent loss of heterozygosity on the long ann of chromosome 6: identification of two distinct regions of deletion in childhood acute lymphoblastic leukemia.Cancer Res, 1998, 58 (12): 2618-2623.
  • 5Baccichet A, Qualman S K, Sinnett D. Allelic loss in childhood acute lymphoblastic leukemia. Leuk Res, 1997, 21 (9): 817-823.
  • 6Takeuchi S, Tsukasaki K, Bartram C R, et al. Long-term study of the clinical significance of loss of heterozygosity in childhood acute lymphoblastic leukemia. Leukemia, 2003, 17 (1): 149- 154.
  • 7Scholz I, Popp S, Granzow M, et al. Comparative genomic hybridization in childhood acute lymphoblastic leukemia:correlation with interphase cytogenetics and loss of heterozygosity analysis. Cancer Genet Cytogenet, 2001, 124 (2): 89-97.
  • 8Gerard B, Cave H, Guidal C, et al. Delineation ofa 6 cM commonly deleted region in childhood acute lymphoblastic leukemia on the 6q chromosomal arm. Leukemia, 1997, 11 (2): 228-232.
  • 9Jackson A, Carrara P, Duke V, et al. Deletion of 6q16-q21 in human lymphoid malignancies: a mapping and deletion analysis. Cancer Res, 2000, 60 (11): 2775-2779.
  • 10De Young M P, Damania H, Scheurle D, et al. Bioinformatics-based discovery of a novel factor with apparent specificity to colon cancer.In Vivo, 2002, 16 (4): 239-248.

共引文献22

同被引文献59

引证文献7

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部